Offering proven success and lasting results, ketamine represents hope and healing in the treatment of depression, anxiety, ...

Roughly one in ten Americans suffers from major depressive disorder (MDD) at any given time. In total, up to 20 percent of ...

This is an important study that combines replications of findings and novel detailed MRI investigations to assess the impact of environmental enrichment and maternal behavior on mice brain structure ...

Mr. Musk was using ketamine regularly on the campaign trail last year, according to an article in The New York Times. He was also using MDMA and psilocybin mushrooms, The Times found.

A team of researchers at the University of California, Davis, made small tweaks to the molecular structure of lysergic acid diethylamide (LSD) to see if it could be turned into an effective brain ...

Esketamine (or s-ketamine) is an enantiomer of ketamine (with similar molecular structure), and the journal Medicine reports esketamine is approximately twice as potent as ketamine.

Ketamine has been used since the 1960s as an anesthetic, but in 2000, the first trial of far lower doses of ketamine proved its rapid efficacy in treating major depression and suicidal ideation.

Published in September in Molecular Psychiatry, the UB discovery will also help scientists identify how depression originates in the brain, and will stimulate research into using ketamine and ...

Ketamine has been used since the 1960s as an anesthetic, but in 2000, the first trial of far lower doses of ketamine proved its rapid efficacy in treating major depression and suicidal ideation.

Ketamine is approved for anesthesia but the Food and Drug Administration (FDA) has not approved it for depression, except for a pricey version of the drug known as Spravato (esketamine.) ...

UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms of major depression ...

BUFFALO, N.Y. — University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, ...